Chirag B. Shah

Chirag B. Shah, PhD is Vice President of Research and Development Engineering and Quality Systems at Arch Therapeutics. Dr. Shah brings broad 20 years of proven record of technology and product development, advanced research and device performance evaluations covering vascular, advanced wound care and infection control products. Prior to joining Arch Therapeutics, Dr. Shah was a Senior Director of Biomaterials R&D Center of Excellence in Vascular Therapies GBU at Covidien for 10 years and contributed to peripheral and neurovascular, wound care and renal access products and technologies development. Earlier, Dr. Shah worked at Biolink Corporation focusing on development of a liquid device product for infection and clotting prevention. Prior to that, Dr. Shah worked at USCI division of C.R. Bard, focusing on myocardial bioactive implant and thromboresistant stent coating technologies.

Dr. Shah earned a PhD from University of Rhode Island in 1993 and Executive Leadership Certificates from Cornell and MIT in 2011 and 2009, respectively. Dr. Shah is listed as co-inventor on 25 US issued patents and published applications.